as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹927.7
Change
-31.9 (-3.32%)
Open
₹959.6
Prev. Close
₹959.6
Day High
₹959.65
Day Low
₹924.0
Volume Analysis
Traded
25,862
Delivered
13,842
Delivery %
53.52%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Trading within 3% of its 52-week low (₹916.0)
- •Below-average fundamentals quality score (47/100)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹985.89 | ₹972.77 | ₹950.24 | ₹937.12 | ₹914.59 | ₹901.47 | ₹878.94 |
| Fibonacci | ₹972.77 | ₹959.15 | ₹950.74 | ₹937.12 | ₹923.5 | ₹915.09 | ₹901.47 |
| Camarilla | ₹937.5 | ₹934.24 | ₹930.97 | ₹937.12 | ₹924.43 | ₹921.16 | ₹917.9 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-58.13%
1 Week
-10.76%
1 Month
-4.9%
3 Months
-28.36%
6 Months
-33.89%
1 Year
-91.01%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹1,257.85
Current price is at or below the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
9.98%
Net margin 10.8% × asset turnover 0.79x × equity multiplier 1.17x
Company Overview
Sector
Chemicals
Market Cap
₹1,648 Cr
P/E (TTM)
11.8
ROE
12.2%
Book Value
₹802.0
Face Value
₹5.0
Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.
TopFund Analysis
Bharat Rasayan Ltd scores weakly on TopFund's composite fundamentals check within the Chemicals sector, at 47/100. The strongest factor is Financial Strength (100/100), while Momentum (4/100) is the weakest area to weigh before deciding. Notably: Trading within 3% of its 52-week low (₹916.0); below-average fundamentals quality score (47/100).
TopFund Score — Fundamentals Quality
47/100 — WeakData confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
- +Company is almost debt free.
- −The company has delivered a poor sales growth of 2.60% over past five years.
- −Company has a low return on equity of 11.5% over last 3 years.
- −Dividend payout has been low at 0.56% of profits over last 3 years
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
37th AGM held on 24 September 2026; annual report adopted, 0.50 dividend recommended, and key resolutions placed.
Trading window closed from October 1, 2026 until 48 hours after Q2 FY2027 results.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 263 | 233 | 310 | 282 | 328 | 256 | 307 | 377 | 286 | 270 | 308 | 338 | 353 |
| Expenses + | 250 | 207 | 240 | 244 | 281 | 215 | 270 | 308 | 253 | 228 | 259 | 287 | 324 |
| Operating Profit | 13 | 26 | 69 | 38 | 47 | 42 | 37 | 69 | 33 | 43 | 49 | 51 | 28 |
| OPM % | 4.9% | 11.0% | 22.0% | 14.0% | 14.0% | 16.0% | 12.0% | 18.0% | 12.0% | 16.0% | 16.0% | 15.0% | 8.0% |
| Other Income + | 4 | 4 | 22 | 22 | 7 | 18 | 6 | -8 | 11 | 17 | 10 | 6 | 11 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 6 | 7 | 6 | 6 | 6 | 7 | 7 | 6 | 6 | 7 | 7 | 7 | 8 |
| Profit before tax | 10 | 22 | 84 | 53 | 46 | 52 | 35 | 54 | 36 | 52 | 51 | 49 | 30 |
| Tax % | 39.0% | 29.0% | 20.0% | 19.0% | 30.0% | 21.0% | 27.0% | 26.0% | 23.0% | 23.0% | 26.0% | 24.0% | 29.0% |
| Net Profit + | 6 | 15 | 67 | 43 | 32 | 41 | 25 | 40 | 28 | 40 | 38 | 37 | 21 |
| EPS in Rs | 4 | 9 | 40 | 26 | 19 | 24 | 15 | 24 | 17 | 24 | 23 | 22 | 13 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | -10 | -25 | 1 | 18 | 25 | 10 | -1 | 34 | -13 | 5 | 0 | -10 | 23 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 989 | 1,213 | 1,091 | 1,301 | 1,234 | 1,044 | 1,171 | 1,240 | 1,269 |
| Expenses + | 802 | 983 | 852 | 1,050 | 1,043 | 926 | 996 | 1,041 | 1,098 |
| Operating Profit | 188 | 230 | 240 | 250 | 191 | 118 | 175 | 199 | 171 |
| OPM % | 19.0% | 19.0% | 22.0% | 19.0% | 15.0% | 11.0% | 15.0% | 16.0% | 13.0% |
| Other Income + | 1 | 14 | 6 | 16 | 15 | 35 | 42 | 25 | 44 |
| Interest | 16 | 16 | 4 | 7 | 6 | 3 | 5 | 5 | 4 |
| Depreciation | 17 | 22 | 26 | 25 | 26 | 26 | 27 | 26 | 29 |
| Profit before tax | 155 | 205 | 215 | 234 | 174 | 123 | 185 | 193 | 182 |
| Tax % | 28.0% | 23.0% | 24.0% | 25.0% | 28.0% | 23.0% | 24.0% | 25.0% | — |
| Net Profit + | 112 | 158 | 164 | 176 | 125 | 96 | 141 | 146 | 137 |
| EPS in Rs | 66 | 93 | 96 | 106 | 75 | 58 | 85 | 88 | 82 |
| Dividend Payout % | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | 0.0% | 1.0% | — |
| Sales growth | — | 23 | -10 | 19 | -5 | -15 | 12 | 6 | 4 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Reserves | 405 | 560 | 723 | 766 | 889 | 984 | 1,126 | 1,266 | 1,324 |
| Borrowings + | 247 | 94 | 58 | 174 | 28 | 80 | 85 | 1 | 53 |
| Other Liabilities + | 100 | 94 | 122 | 142 | 152 | 129 | 193 | 157 | 177 |
| Total Liabilities | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 | 1,433 | 1,563 |
| Fixed Assets + | 150 | 203 | 191 | 228 | 225 | 230 | 230 | 246 | 264 |
| CWIP | 35 | 18 | 18 | 11 | 11 | 6 | 15 | 46 | 43 |
| Investments | 0 | 9 | 150 | 43 | 67 | 143 | 298 | 324 | 233 |
| Other Assets + | 570 | 522 | 549 | 803 | 771 | 818 | 865 | 816 | 1,023 |
| Total Assets | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 | 1,433 | 1,563 |
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 8 | 8 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -52 | 263 | 170 | -65 | 213 | 41 | 172 | 132 |
| Cash from Investing Activity + | -46 | -53 | -149 | 64 | -43 | -76 | -148 | -75 |
| Cash from Financing Activity + | 102 | -169 | -40 | -25 | -152 | 49 | -1 | -89 |
| Net Cash Flow | 4 | 40 | -19 | -26 | 18 | 14 | 23 | -33 |
| Free Cash Flow | -100 | 204 | 160 | -121 | 191 | 14 | 137 | 59 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -5 | 137 | 92 | -3 | 138 | 59 | 120 | 88 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 22.09% | 22.09% | 22.07% | 21.9% | 21.96% | 21.77% | 21.71% | 21.79% | 22.05% | 22.33% | 22.61% | 22.72% |
| Promoters | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% |
| FII | 0.34% | 0.34% | 0.35% | 0.46% | 0.45% | 0.49% | 0.56% | 0.47% | 0.43% | 0.54% | 0.41% | 0.58% |
| DII | 2.57% | 2.57% | 2.59% | 2.64% | 2.6% | 2.75% | 2.74% | 2.75% | 2.52% | 2.14% | 2.0% | 1.7% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Bharat Rasayan Ltd (this stock) | 1,648 | 11.8 | 1.24 | 12.2% |
| I G Petrochemicals Ltd | 1,691 | 10.0 | 1.15 | 0.16% |
| Insecticides (i) Ltd | 1,604 | 13.1 | 1.2 | 12.0% |
| Oriental Aromatics Ltd | 1,596 | 154.0 | 2.38 | 0.5% |
| Indokem Ltd. | 1,701 | 753.0 | 25.92 | 1.69% |
| Gocl Corporation Limited | 1,701 | 6.12 | 0.55 | 56.7% |
| Bhageria Industries Ltd | 1,594 | 14.1 | 2.35 | 7.03% |
Which Mutual Funds Hold Bharat Rasayan Ltd?
Frequently Asked Questions about Bharat Rasayan Ltd
Bharat Rasayan Ltd (BHARATRAS) closed at ₹927.7 on NSE on 19 November 2026, down 31.9 (3.32%) from the previous close.
Bharat Rasayan Ltd trades on the NSE (National Stock Exchange of India) under the symbol BHARATRAS.
Bharat Rasayan Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 11.8.
Bharat Rasayan Ltd has a dividend yield of 0.05%.
Bharat Rasayan Ltd's 52-week high is ₹2,853.0 and its 52-week low is ₹916.0.
Bharat Rasayan Ltd has a market capitalisation of ₹1,648 crore.
Bharat Rasayan Ltd has a TopFund Quality Score of 47/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Bharat Rasayan Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.